CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The OSTEOGROW project is conducting clinical trials to test a novel therapy for bone regeneration using a recombinant human protein combined with a patient's own blood-derived material. This approach aims to enhance healing in conditions like fractures and osteotomies.
Goals:
We will carry out a regenerative medicine clinical trial of the therapeutic system OSTEOGROW for regenerating bone through harnessing a novel bone regenerative product to accelerate and enhance bone repair.The osteogenic regenerative product is composed of an autologous carrier and a biologically active recombinant human protein offering a therapeutic solution in bone regeneration superior to currently available options.The autologous carrier is a whole blood coagulum derived (WBCD) from…
UNIVERSITY OF ZAGREB, SCHOOL OF MEDICINE
SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Croatia, Kalinovica
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Sweden, Linköping
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Czechia, Konarovice
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
MEDIZINISCHE UNIVERSITAET WIEN
Austria, Wien
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
